AI assistant
Sending…
FIBROGEN INC — Director's Dealing 2024
Jun 7, 2024
34576_dirs_2024-06-06_dd2ad562-ab85-4a27-b61a-89c822ecd1c9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2024-06-05
Reporting Person: Cravatt Benjamin (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-06-05 | Stock Option (Right to Buy) | $1.21 | A | 70000 | Acquired | 2034-06-04 | Common Stock (70000) | Direct |
Footnotes
F1: Options vest on the earlier of June 16, 2025 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date.
More from FIBROGEN INC
Regulatory Filings
2026
Apr 9
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Regulatory Filings
2026
Jan 7
Director's Dealing
2025
Dec 9
Director's Dealing
2025
Dec 9
Director's Dealing
2025
Nov 17
Major Shareholding Notification
2025
Nov 15
Interim / Quarterly Report
2025
Nov 10
Regulatory Filings
2025
Nov 10